Loading ...

Best Available Therapy Vs. Autologous Hematopoietic Stem Cell Transplant For MS

(

BEAT-MS

)

ITN Protocol #:

ITN077AI

Branded Name:

BEAT-MS

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Enrollment

Summary:

A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Jeffrey Cohen, MDCOHENJ@ccf.org

Work: 

(216)445-8110

Protocol Chair

Paolo Muraro, MD PhDp.muraro@imperial.ac.uk

Work: 

020-7594-7014

Protocol Chair

George Georges, MDgeorge.georges@nm.org

Work: 

(312) 694-0846

Protocol Chair

Patti Tostaptosta@immunetolerance.org

Work: 

415-353-4421

Protocol Chair

Kristin Rykerkryker@immunetolerance.org

Work: 

415-353-4405

Protocol Chair

Laura Cooney, PhDlcooney@immunetolerance.org

Work: 

734-274-1149

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151

Protocol Chair

Dawn Smilek, MD PhDdsmilek@immunetolerance.org

Work: 

415-353-4308

Protocol Chair

Julia Goldsteinjulia.goldstein@nih.gov

Work: 

240-627-3509

Protocol Chair

Bill Barry, PhDBill_Barry@rhoworld.com

Work: 

919-595-6867

Protocol Chair

Megan Cartermegan.carter@ppdi.com

Work: 

(910) 558-6490